In hepatocellular carcinoma miR-494 up-regulates the AKT/mTOR pathway and is involved in Sorafenib resistance. (10th February 2016) - Pollutri, D.; Patrizi, C.; Marinelli, S.; Ferracin, M.; Negrini, M.; Toaldo, M. Baron; Bolondi, L.; Gramantieri, L.; Fornari, F.